rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-2-25
|
pubmed:abstractText |
Current prosthetic alternatives to autologous vascular grafts remain poor in terms of patency. Growing biologic blood vessels has been proposed as an alternative. In this work, the authors demonstrate a method for producing a tissue-engineered vascular graft (TEVG) with self-derived endothelial cells, smooth muscle cells, and allogenic acellular matrix in vitro. The aim of this study was to find out if the graft is suitable as the carotid artery substitute.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1536-3708
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
297-303
|
pubmed:meshHeading |
pubmed-meshheading:19240529-Animals,
pubmed-meshheading:19240529-Bioartificial Organs,
pubmed-meshheading:19240529-Blood Vessel Prosthesis,
pubmed-meshheading:19240529-Carotid Arteries,
pubmed-meshheading:19240529-Cells, Cultured,
pubmed-meshheading:19240529-Dogs,
pubmed-meshheading:19240529-Endothelial Cells,
pubmed-meshheading:19240529-Extracellular Matrix,
pubmed-meshheading:19240529-Models, Animal,
pubmed-meshheading:19240529-Myocytes, Smooth Muscle,
pubmed-meshheading:19240529-Saphenous Vein,
pubmed-meshheading:19240529-Skin, Artificial,
pubmed-meshheading:19240529-Tissue Engineering,
pubmed-meshheading:19240529-Tissue Scaffolds,
pubmed-meshheading:19240529-Transplantation, Homologous
|
pubmed:year |
2009
|
pubmed:articleTitle |
Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
|
pubmed:affiliation |
Department of Surgery, 2nd Hospital of Harbin Medical University, Harbin, HLJ, China. dapingyang@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|